Clinical Trials Logo
  1. Home
  2. Benign Prostate Hyperplasia
  3. NCT02021032

Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostate Hyperplasia Clinical Trial

Official title:
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Clinical Trial Summary

The primary objective of the post-marketing study is to collect safety and effectiveness data for 5 years on subjects treated with Prolieve®. The collection of 5-year safety information will be used to evaluate the occurrence of any long-term side effects from the treatment. The collection of long-term effectiveness data on subjects treated with Prolieve® will provide information on the long-term effects of treatment and time to re- treatment (any treatment initiated for BPH since Prolieve'" treatment, including a second treatment with Prolieve").

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02021032
Study type Interventional
Source Medifocus, Inc.
Contact Varada Bidargaddi
Email varada.bidargaddi@kentron.co
Status Recruiting
Phase Phase 4
Start date February 2006
Completion date August 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT01942551 - Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride Phase 1
Completed NCT01436877 - Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia N/A
Completed NCT02822924 - Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia N/A
Completed NCT02390882 - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH Phase 3
Completed NCT02839122 - A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects Phase 1
Not yet recruiting NCT01861041 - Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy. Phase 4
Completed NCT02332538 - HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH N/A
Completed NCT01835860 - Prostatic Artery Embolization for Benign Prostatic Hyperplasia Phase 2/Phase 3
Completed NCT01665586 - Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study N/A
Completed NCT02038868 - A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia Phase 2
Completed NCT02506465 - Pivotal Study to Assess the Safety and Effectiveness of the iTind Device N/A
Completed NCT01675895 - Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration Phase 4
Completed NCT02483819 - Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients N/A
Recruiting NCT02827578 - Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia Phase 3
Completed NCT02352311 - Safety and Pharmacokinetic Characteristics of DKF-313 Phase 1
Completed NCT01627522 - Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate Phase 2/Phase 3
Completed NCT01494337 - Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) Phase 4
Completed NCT01952912 - Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates N/A
Active, not recruiting NCT01736033 - Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients Phase 4
Completed NCT00861588 - Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia N/A